Overview

Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors

Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if panobinostat taken with cisplatin and pemetrexed can be used safely without increasing side effects and that the combination will have a better effect than platinum-based doublet chemotherapy alone.
Phase:
Phase 1
Details
Lead Sponsor:
University of California, Davis
Collaborator:
Novartis Pharmaceuticals
Treatments:
Cisplatin
Panobinostat
Pemetrexed